384 research outputs found
Parallel String Sample Sort
We discuss how string sorting algorithms can be parallelized on modern
multi-core shared memory machines. As a synthesis of the best sequential string
sorting algorithms and successful parallel sorting algorithms for atomic
objects, we propose string sample sort. The algorithm makes effective use of
the memory hierarchy, uses additional word level parallelism, and largely
avoids branch mispredictions. Additionally, we parallelize variants of multikey
quicksort and radix sort that are also useful in certain situations.Comment: 34 pages, 7 figures and 12 table
Tree-based Coarsening and Partitioning of Complex Networks
Many applications produce massive complex networks whose analysis would
benefit from parallel processing. Parallel algorithms, in turn, often require a
suitable network partition. For solving optimization tasks such as graph
partitioning on large networks, multilevel methods are preferred in practice.
Yet, complex networks pose challenges to established multilevel algorithms, in
particular to their coarsening phase.
One way to specify a (recursive) coarsening of a graph is to rate its edges
and then contract the edges as prioritized by the rating. In this paper we (i)
define weights for the edges of a network that express the edges' importance
for connectivity, (ii) compute a minimum weight spanning tree with
respect to these weights, and (iii) rate the network edges based on the
conductance values of 's fundamental cuts. To this end, we also (iv)
develop the first optimal linear-time algorithm to compute the conductance
values of \emph{all} fundamental cuts of a given spanning tree. We integrate
the new edge rating into a leading multilevel graph partitioner and equip the
latter with a new greedy postprocessing for optimizing the maximum
communication volume (MCV). Experiments on bipartitioning frequently used
benchmark networks show that the postprocessing already reduces MCV by 11.3%.
Our new edge rating further reduces MCV by 10.3% compared to the previously
best rating with the postprocessing in place for both ratings. In total, with a
modest increase in running time, our new approach reduces the MCV of complex
network partitions by 20.4%
Novel birch pollen specific immunotherapy formulation based on contiguous overlapping peptides.
BACKGROUND: Synthetic contiguous overlapping peptides (COPs) may represent an alternative to allergen extracts or recombinant allergens for allergen specific immunotherapy. In combination, COPs encompass the entire allergen sequence, providing all potential T cell epitopes, while preventing IgE conformational epitopes of the native allergen.
METHODS: Individual COPs were derived from the sequence of Bet v 1, the major allergen of birch pollen, and its known crystal structure, and designed to avoid IgE binding. Three sets of COPs were tested in vitro in competition ELISA and basophil degranulation assays. Their in vivo reactivity was determined by intraperitoneal challenge in rBet v 1 sensitized mice as well as by skin prick tests in volunteers with allergic rhinoconjunctivitis to birch pollen.
RESULTS: The combination, named AllerT, of three COPs selected for undetectable IgE binding in competition assays and for the absence of basophil activation in vitro was unable to induce anaphylaxis in sensitized mice in contrast to rBet v 1. In addition no positive reactivity to AllerT was observed in skin prick tests in human volunteers allergic to birch pollen. In contrast, a second set of COPs, AllerT4-T5 displayed some residual IgE binding in competition ELISA and a weak subliminal reactivity to skin prick testing.
CONCLUSIONS: The hypoallergenicity of contiguous overlapping peptides was confirmed by low, if any, IgE binding activity in vitro, by the absence of basophil activation and the absence of in vivo induction of allergic reactions in mouse and human.
TRIAL REGISTRATION: ClinicalTrials.gov NCT01719133
study protocol for a randomized controlled trial
Background Osteoarthritis (OA) is a heterogeneous group of conditions with
disturbed integrity of articular cartilage and changes in the underlying bone.
The pathogenesis of OA is multifactorial and not just a disease of older
people. Hydroxychloroquine (HCQ) is a disease-modifying anti-rheumatic drug
(DMARD) typically used for the treatment of various rheumatic and dermatologic
diseases. Three studies of HCQ in OA, including one abstract and one letter,
are available and use a wide variety of outcome measures in small patient
populations. Despite initial evidence for good efficacy of HCQ, there has been
no randomized, double-blind, and placebo-controlled trial in a larger patient
group. In the European League Against Rheumatism (EULAR), evidence-based
recommendations for the management of hand OA, HCQ was not included as a
therapeutic option because of the current lack of randomized clinical trials.
Methods/Design OA TREAT is an investigator-initiated, multicenter, randomized,
double-blind, placebo-controlled trial. A total of 510 subjects with
inflammatory and erosive hand OA, according to the classification criteria of
the American College of Rheumatology (ACR), with recent X-ray will be
recruited across outpatient sites, hospitals and universities in Germany.
Patients are randomized 1:1 to active treatment (HCQ 200 to 400 mg per day) or
placebo for 52 weeks. Both groups receive standard therapy (non-steroidal
anti-inflammatory drugs [NSAID], coxibs) for OA treatment, taken steadily two
weeks before enrollment and continued further afterwards. If disease activity
increases, the dose of NSAID/coxibs can be increased according to the drug
recommendation. The co-primary clinical endpoints are the changes in
Australian-Canadian OA Index (AUSCAN, German version) dimensions for pain and
hand disability at week 52. The co-primary radiographic endpoint is the
radiographic progression from baseline to week 52. A multiple endpoint test
and analysis of covariance will be used to compare changes between groups. All
analyses will be conducted on an intention-to-treat basis. Discussion The OA
TREAT trial will examine the clinical and radiological efficacy and safety of
HCQ as a treatment option for inflammatory and erosive OA over 12 months. OA
TREAT focuses on erosive hand OA in contrast to other current studies on
symptomatic hand OA, for example, HERO [Trials 14:64, 2013]
Comparison of two oral probiotic preparations in a randomized crossover trial highlights a potentially beneficial effect of Lactobacillus paracasei NCC2461 in patients with allergic rhinitis.
BACKGROUND: There is promising but conflicting evidence to recommend the addition of probiotics to foods for prevention and treatment of allergy. Based on previous studies with fermented milk containing Lactobacillus paracasei NCC2461, we aimed to compare the effect of a powder form of the latter probiotic with the effect of a blend of Lactobacillus acidophilus ATCC SD5221 and Bifidobacterium lactis ATCC SD5219 in patients with allergic rhinitis.
METHODS: A double-blind, randomized, cross-over study, involving 31 adults with allergic rhinitis to grass pollen, was performed outside the grass pollen season (registration number: NCT01233154). Subjects received each product for 4-weeks in two phases separated by a wash-out period of 6 to 8 weeks. A nasal provocation test was performed before and after each 4-week product intake period, and outcome parameters (objective and subjective clinical symptoms; immune parameters) were measured during and/or 24 hours after the test.
RESULTS: Out of the 31 subject enrolled, 28 completed the study. While no effect was observed on nasal congestion (primary outcome), treatment with NCC2461 significantly decreased nasal pruritus (determined by VAS), and leukocytes in nasal fluid samples, enhanced IL-5, IL-13 and IL-10 production by peripheral blood mononuclear cells in an allergen specific manner and tended to decrease IL-5 secretion in nasal fluid, in contrast to treatment with the blend of L. acidophilus and B. lactis.
CONCLUSIONS: Despite short-term consumption, NCC2461 was able to reduce subjective nasal pruritus while not affecting nasal congestion in adults suffering from grass pollen allergic rhinitis. The associated decrease in nasal fluid leukocytes and IL-5 secretion, and the enhanced IL-10 secretion in an allergen specific manner may partly explain the decrease in nasal pruritus. However, somewhat unexpected systemic immune changes were also noted. These data support the study of NCC2461 consumption in a seasonal clinical trial to further demonstrate its potentially beneficial effect
Age-related improvement in complex language comprehension: Results of a cross-sectional study with 361 children aged 5 to 15
We investigated age-related improvement in speed and accuracy of complex language comprehension with 361 children attending kindergarten and the 2nd, 4th, 6th, 7th, and 8th grades. Language comprehension was measured using both the neuropsychological procedure proposed by Luria (1966, 1980) and an adapted version of the Token Test. Levels of short-term memory and verbal intelligence were controlled for in the evaluation of language comprehension. The findings show that the accuracy of language comprehension continued to develop until the 6th grade, whereas the speed of language comprehension continued to improve up until the 7th grade. We thus conclude that the complex language comprehension of children is not fully developed until early adolescence. We further contend that the speed of complex language comprehension appears to be more sensitive than accuracy with respect to measuring developmental differences
Motor coordination, working memory, and academic achievement in a normative adolescent sample: Testing a mediation model
The aim of the present study was to examine whether the relationship between motor coordination and academic achievement is mediated by working memory (WM) in a normative adolescent sample. Participants included 93 adolescents aged 12–16. The Movement Assessment Battery for Children-2 provided three indicators of motor coordination (Manual Dexterity, Aiming and Catching, and Balance), the WM Index of the Wechsler Intelligence Scale for Children-IV and the N-back paradigm provided two indicators of WM, and the Wechsler Individual Achievement Test-II provided three indicators of academic achievement (Word Reading, Spelling, and Numerical Operations). Structural equation modeling, controlling for verbal comprehension, attention deficit hyperactivity disorder symptoms, and socioeconomic status, suggested that the association between motor coordination and academic achievement may be best understood in terms of a mechanism whereby motor coordination (specifically, Aiming and Catching skills) has an indirect impact on academic outcomes via WM. These findings have important implications for the assessment and treatment of motor coordination and learning difficulties as well as in increasing the understanding of the possible neural mechanisms underpinning the relationship between these areas
Cost-Effectiveness of Preoperative Screening and Eradication of Staphylococcus aureus Carriage
BACKGROUND: Preoperative screening for nasal S. aureus carriage, followed by eradication treatment of identified carriers with nasal mupirocine ointment and chlorhexidine soap was highly effective in preventing deep-seated S. aureus infections. It is unknown how cost-effectiveness of this intervention is affected by suboptimal S. aureus screening. We determined cost-effectiveness of different preoperative S. aureus screening regimes. METHODS: We compared different screening scenarios (ranging from treating all patients without screening to treating only identified S. aureus carriers) to the base case scenario without any screening and treatment. Screening and treatment costs as well as costs and mortality due to deep-seated S. aureus infection were derived from hospital databases and prospectively collected data, respectively. RESULTS: As compared to the base case scenario, all scenarios are associated with improved health care outcomes at reduced costs. Treating all patients without screening is most cost-beneficial, saving €7339 per life year gained, as compared to €3330 when only identified carriers are treated. In sensitivity analysis, outcomes are susceptible to the sensitivity of the screening test and the efficacy of treatment. Reductions in these parameters would reduce the cost-effectiveness of scenarios in which treatment is based on screening. When only identified S. aureus carriers are treated costs of screening should be less than €6.23 to become the dominant strategy. CONCLUSIONS: Preoperative screening and eradication of S. aureus carriage to prevent deep-seated S. aureus infections saves both life years and medical costs at the same time, although treating all patients without screening is the dominant strategy, resulting in most health gains and largest savings
Clinical outcomes and safety of rituximab treatment for patients with systemic lupus erythematosus (SLE) - results from a nationwide cohort in Germany (GRAID)
ObjectiveThe objective of this article is to evaluate the safety and clinical outcome of rituximab treatment in systemic lupus erythematosus (SLE) patients refractory to standard of care therapy in a real-life setting in Germany. MethodsThe GRAID registry included patients with different autoimmune diseases who were given off-label treatment with rituximab. Data on safety and clinical response were collected retrospectively. In SLE patients, clinical parameters included tender and swollen joint counts, fatigue, myalgia, general wellbeing, Raynaud's and the SLEDAI index. Laboratory tests included dsDNA antibody titres, complement factors, hematologic parameters and proteinuria. Finally, the investigators rated their patients as non-, partial or complete responders based on clinical grounds. ResultsData from 85 SLE patients were collected, 69 female and 16 male, with a mean disease duration of 9.8 years. The mean follow-up period was 9.67.4 months, resulting in 66.8 patient years of observation. A complete response was reported in 37 patients (46.8%), partial response in 27 (34.2%), no response in 15 (19.0%). On average, major clinical as well as laboratory efficacy parameters improved substantially, with the SLEDAI decreasing significantly from 12.2 to 3.3 points. Concerning safety, one infusion reaction leading to discontinuation of treatment occurred. Infections were reported with a rate of 19.5 (including six severe infections) per 100 patient years. ConclusionWith the restrictions of a retrospective data collection, the results of this study confirm data of other registries, which suggest a favourable benefit-risk ratio of rituximab in patients with treatment-refractory SLE
- …